Skip to main content
. 2010 Jan 12;102(3):475–481. doi: 10.1038/sj.bjc.6605522

Figure 2.

Figure 2

Kaplan–Meier curves of progression-free survival for advanced oesophagogastric cancer patients treated with weekly docetaxel, plus cisplatin and 5-fluorouracil (wTCF; n=50), or weekly docetaxel with capecitabine (wTX; n=56).

HHS Vulnerability Disclosure